Navigation

PRESS RELEASES

AGT CSO, David Pauza, to Present HIV cure data At The Cell & Gene Meeting on the Mesa

By AGT | Sep 29, 2017
Filed Under:

ROCKVILLE, MD., September. 26, 2017 (GLOBE NEWSWIRE) — American Gene Technologies International Inc. (AGT), a gene technology company focusing on a lentiviral delivery platform, today announced that Chief Science Officer C. David Pauza, Ph.D., will present at the upcoming Cell & Gene Meeting on the Mesa being held from October 4-6, 2017, in La Jolla, CA. Dr. Pauza will speak on… [Read More]

AGT Builds Montgomery County Gene & Cell Therapy Momentum

By AGT | Sep 25, 2017
Filed Under:

Fast Growing Maryland Biotech Company Moves to a 24,000 Sq. Ft. Location and Will Host Ribbon Cutting Ceremony on October 23, 2017. September 25, 2017. Montgomery County, MD: American Gene Technologies (AGT), a private Maryland biotechnology company developing cures and treatments for Infectious diseases, cancers and monogenic disorders, will celebrate the grand opening of its new 24,000 sq. ft.  laboratory and offices. From its… [Read More]

American Gene Technologies Inc. Appoints Julia R. Brown to its Board of Directors

By AGT | Sep 11, 2017
Filed Under:

ROCKVILLE, Md., Sept. 11, 2017 (GLOBE NEWSWIRE) — American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company with a broad and robust lentiviral drug-development platform, today announced the appointment of Julia R. Brown to its board of directors. Jeffrey A. Galvin CEO and Founder “We are excited to announce Julia’s appointment to the board,” said Jeff… [Read More]

AGT’s CEO to Present at the 2017 BIO International Convention

By AGT | Jun 7, 2017
Filed Under:

  ROCKVILLE, MD, June 07, 2017 American Gene Technologies International Inc. (AGT), a genetic medicine company with a broad, robust lentiviral delivery platform, announced today that its CEO, Jeff Galvin, is presenting at the upcoming BIO International Convention. The Convention is being held on June 19-22, at the San Diego Convention Center in California. AGT’s presentation is schedule for Monday,… [Read More]

AGT CEO, Jeff Galvin, to Present at HIMSS Precision Medicine Summit

By AGT | May 31, 2017
Filed Under:

ROCKVILLE, MD, May 31, 2017 — American Gene Technologies International Inc. (AGT), a gene technology company with a broad and robust lentiviral delivery platform, today announced that Jeff Galvin, CEO, will present at the upcoming Health Information Management System Society (HIMSS) Precision Medicine Summit, being held from June 12-13, 2017, in Boston. Mr. Galvin will share his vision for the… [Read More]

American Gene Technologies Announces Appointment of C. Neil Lyons as Chief Financial Officer

By AGT | Apr 12, 2017
Filed Under:

Rockville, Maryland, April 12, 2017 American Gene Technologies International Inc. (AGT), a genetic drug development company, announced the appointment of C. Neil Lyons as Executive Vice President and Chief Financial Officer.   Mr. Lyons joins AGT with over a decade of experience leading finance for clinical-stage, publicly-traded biotechnology companies.  Mr. Lyons previously served as CFO for Cleveland BioLabs, Inc., a company… [Read More]

American Gene Technologies Announces Collaboration with GeoVax for HIV cure

By AGT | Mar 14, 2017
Filed Under:

Clinical Trial Expected to Commence in 2017   Rockville, MD, March 14, 2017 American Gene Technologies International Inc. (“AGT”) – announced today its collaboration with GeoVax Labs, Inc. (OTCQB: GOVX) for the conduct of a Phase 1 clinical trial investigating AGT’s viral vector technology as a functional cure for HIV infection.   AGT is preparing an investigational new drug application (“IND”) to… [Read More]

AGT’s CEO to Present at the 19th BIO CEO & Investor Conference

By AGT | Feb 3, 2017
Filed Under:

Rockville, MD American Gene Technologies (AGT), a gene technology company with a broad, robust lentiviral delivery platform, announced today that the CEO, Jeff Galvin is presenting at the upcoming BIO CEO & Investor conference. The Conference is being held on February 13 -14, at the Waldorf Astoria New York, New York.  The presentation is schedule for Monday February 13, 2017… [Read More]

AGT’s CEO to Present at NobleCon13

By AGT | Jan 27, 2017
Filed Under:

View: 1.27.16 Press Release – NobleCon13 View: Noble Conference – Investor Presentation View: Webcast

Internationally Recognized Molecular Researcher Joins American Gene Technologies as Collaborator

By AGT | Oct 4, 2016
Filed Under:

ROCKVILLE, MARYLAND (October 4, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Dr. John J. Rossi, PhD as a collaborator on gene therapy research. Dr. Rossi is a leader in the field of molecular biology and a pioneer in the development of RNA-based therapies for human disease.   “For more than three decades, John J…. [Read More]

Subscribe to Our Newsletter

Subscribe to our newsletter to keep up to date with all the latest news about AGT!

Mailchimp sidebar

Follow AGT on Social Media

Send this to a friend